Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

Market for Generic Medications: Integration of Personalized Medicine and Pharmacogenomic Guidance...

23 Mar, 2026

Zacks Industry Analysis Spotlights Teva Pharmaceuticals, Sandoz, and Dr. Reddy's

05 Mar, 2026

Three Generic Pharmaceutical Stocks to Monitor Amid Industry Challenges - Yahoo Finance

04 Mar, 2026

Generic Pharmaceuticals Market Expected to Grow to USD 942.69 Billion by 2033 | - openPR.com

23 Feb, 2026

See More